GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (WBO:REC) » Definitions » Short Interest

Recordati SpA (WBO:REC) Short Interest


View and export this data going back to 2017. Start your Free Trial

What is Recordati SpA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Recordati SpA's Short Interest

For the Drug Manufacturers - General subindustry, Recordati SpA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Recordati SpA's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Short Interest distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Short Interest falls into.


Recordati SpA (WBO:REC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (WBO:REC) » Definitions » Short Interest
Comparable Companies
MIL:VNT MIL:TNXT MIL:AGAIN MIL:DGV MIL:CIRC MIL:RETI MIL:FOS MIL:AIW MIL:XPR MIL:NRST LLY JNJ MRK ABBV LSE:AZN XSWX:NOVN XSWX:ROG AMGN PFE XPAR:SAN
Traded in Other Exchanges
RICFY:USA REC:Italy RECm:UK 0KBS:UK RER1:Germany
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Website
https://www.recordati.com
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (WBO:REC) Headlines